|
For Immediate Release November 3, 2005 Contact: Amaya Smith 202-863-8148
FDA Should Stop Playing Politics with Women's Health
Washington, DC--- Yesterday, the public comment period ended on the decision to make the emergency contraception drug Plan B available for over-the-counter sale. It has been nearly two years since the FDA's advisory committee recommended that the contraceptive Plan B be available for non-prescription sales, yet the drug's approval has been bogged down in the politics of those within the agency who want to interfere with a woman's right to make decisions about her own healthcare.
The FDA's outgoing Commissioner Lester Crawford has repeatedly postponed the decision. Two respected officials have resigned in frustration because Crawford dragged his feet, and made agency decisions based on political influence rather than scientific and clinical evidence. Still, the agency has ignored the opinions of respected medical consultants who agree that the drug is effective and can safely be used by women of all age groups. Last month, Crawford resigned from his post after news reports detailed his failure to fully disclose his financial interests in companies which manufacture drugs regulated by the agency. A Senate committee has opened a bipartisan investigation to determine if Dr. Crawford complied with federal ethics laws and if his financial disclosure statements were accurate.
"The FDA has a duty to examine medicines based on scientific and clinical evidence, yet they have ignored the advice of experts who agree that Plan B is safe for over-the-counter sales," said Democratic National Committee Communications Director Karen Finney. "The FDA has an obligation to impartially review drugs. They should stop dragging their feet and fulfill this obligation instead of playing politics with the reproductive health of American women."
"Crawford's handling of the Plan B approval process represents two of the worst traits of the Bush Administration: the culture of corruption and using narrow ideology to trump science and the interest of a majority of Americans. President Bush should not have appointed someone with significant stock holdings in pharmaceutical companies to run the FDA. President Bush should not have allowed Crawford to inject his right wing ideology into scientific decisions. America deserves a government that will make honest, impartial decisions that promotes Americas' good health, not an extreme right-wing ideology."
###
Paid for and authorized by the Democratic National Committee, www.democrats. org. This communication is not authorized by any candidate or candidate's committee.
|